Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02305550 · ClinicalTrials.gov registry record · NA
A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT02305550: Completed NA study, sponsored by Massachusetts General Hospital.
NCT02305550 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02305550, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Study Design: This is a two-part physiological for a device feasibility. Both studies are proof of concept descriptive pilot studies. The FIRST PART is a study of healthy volunteers and the SECOND PART of patients with pulmonary hypertension at routine cardiac catheterization laboratory (CATH-LABORATORY). Volunteers and patients will be enrolled sequentially; there is no group randomization. Overall hypothesis of this device feasibility study: To test a lightweight and portable method of synthesizing therapeutic levels of inhaled nitric oxide from air by electrical pulsed discharge.
Interventions
- DEVICE electrical pulsed plasma discharge synthesis of nitric oxide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2015-04 |
| Est. Completion | 2016-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02305550
The ClinicalTrials.gov registry entry for NCT02305550 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which electrical pulsed plasma discharge synthesis of nitric oxide is the first listed.
NCT02305550 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02305550 about?
NCT02305550 is a clinical study titled "A Proof of Concept Study of Electrical Discharge Produced Nitric Oxide for Inhalation". Study Design: This is a two-part physiological for a device feasibility. Both studies are proof of concept descriptive pilot studies. The FIRST PART is a study of healthy volunteers and the SECOND PART of patients with pulmonary hypertension at routine cardiac catheterization laboratory (CATH-LABOR...
What is the current status of trial NCT02305550?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2015-04. Estimated completion is 2016-01.
What interventions are being tested in trial NCT02305550?
The interventions under investigation include: electrical pulsed plasma discharge synthesis of nitric oxide (DEVICE).
Who is sponsoring clinical trial NCT02305550?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.